Tianda Pharmaceuticals Revenue

In the year 2025, Tianda Pharmaceuticals had annual revenue of 322.95M HKD, down -2.12%. Tianda Pharmaceuticals had revenue of 186.31M in the half year ending December 31, 2025, a decrease of -18.50%.

Revenue

322.95M

Revenue Growth

-2.12%

P/S Ratio

0.65

Revenue / Employee

526.83K

Employees

613

Market Cap

210.70M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	322.95M	-6.99M	-2.12%
Dec 31, 2024	329.94M	-202.15M	-37.99%
Dec 31, 2023	532.09M	-14.61M	-2.67%
Dec 31, 2022	546.69M	36.74M	7.20%
Mar 31, 2022	509.96M	35.62M	7.51%
Mar 31, 2021	Pro	Pro	Pro
Mar 31, 2020	Pro	Pro	Pro
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Shenzhen Neptunus Interlong Bio-technique Company	1.08B
Extrawell Pharmaceutical Holdings	52.65M
Regent Pacific Group	2.83M
Joyzyme Group	31.47M
Kontafarma China Holdings	914.71M
PuraPharm Corporation	336.11M
Wai Yuen Tong Medicine Holdings	721.27M
Qianhai Health Holdings	677.12M

Revenue Rankings